具体来看，今日上榜的营业部中，沪股通为第四大买入营业部及第二大卖出营业部，买入金额为 1613.34万元，卖出金额为4740.07万元，合计净卖出3126.74万元。 福蓉科技(603327)今日下跌6.80%，全天换手率11.76%，成交额15.06亿元，振幅8.32%。龙虎榜数据显 示，沪股通净卖出3126.74万元，营业部席位合计净卖出5986.98万元。 上交所公开信息显示，当日该股因日跌幅偏离值达-7.50%上榜，沪股通净卖出3126.74万元。 证券时报·数据宝统计显示，上榜的前五大买卖营业部合计成交2.55亿元，其中，买入成交额为8195.19 万元，卖出成交额为1.73亿元，合计净卖出9113.71万元。 | 买/ | 会员营业部名称 | 买入金额（万 | 卖出金额（万 | | --- | --- | --- | --- | | 卖 | | 元） | 元） | | 买一 | 东方财富证券股份有限公司拉萨东环路第二证券营业部 | 1736.41 | | | 买二 | 东方财富证券股份有限公司拉萨金融城南环路证券营业部 | 1624.66 | | | 买三 | 国信证券股份有限公司浙江互联网分公司 ...

Key Points - Company Grinda plans to invest 80 million yuan to subscribe for 1.91% of Muxi's initial public offering shares [1] - Fuyong Technology clarifies that its products do not possess AI capabilities [1] - Bohui Paper Industry intends to invest 1.7 billion yuan to establish a project with an annual production capacity of 320,000 tons of chemical pulp [1] - Jinggong Technology has won the bid for the Wuhan Qingshan high-performance carbon fiber production base project [1] - Yonghe Intelligent Control plans to transfer 100% equity and debt of its wholly-owned subsidiary Chengdu Shanshui [2] - Zhigang Home plans to repurchase shares with an investment of 80 million to 110 million yuan [2] - Meikailong's shareholder Hangzhou Haoyue intends to reduce its holdings by no more than 131 million shares [2] - International Medical plans to raise no more than 1.008 billion yuan through a private placement [2] - Guizhou Bailin's actual controller Jiang Wei has received a notice of investigation from the Securities Regulatory Commission [2]

上交所公开信息显示，当日该股因日振幅值达19.88%上榜，沪股通净买入733.96万元。 证券时报·数据宝统计显示，上榜的前五大买卖营业部合计成交3.24亿元，其中，买入成交额为1.79亿 元，卖出成交额为1.45亿元，合计净买入3389.43万元。 具体来看，今日上榜的营业部中，沪股通为第二大买入营业部及第一大卖出营业部，买入金额为 4665.85万元，卖出金额为3931.89万元，合计净买入733.96万元。 福蓉科技(603327)今日上涨2.86%，全天换手率16.04%，成交额20.80亿元，振幅19.88%。龙虎榜数据显 示，沪股通净买入733.96万元，营业部席位合计净买入2655.47万元。 10月30日公司发布的三季报数据显示，前三季度公司共实现营业收入19.10亿元，同比增长10.23%，实 现净利润8152.52万元，同比下降42.69%。（数据宝） 福蓉科技12月4日交易公开信息 | 买/ | 会员营业部名称 | 买入金额（万 | 卖出金额（万 | | --- | --- | --- | --- | | 卖 | | 元） | 元） | | 买一 | 瑞银证券有限责任公司上海花园石桥路证 ...

Group 1 - Dongfang Electric announced that three executives plan to reduce their holdings by a total of no more than 30,000 shares due to personal financial needs [1] - Yahu Pharmaceutical's APL-1401 clinical trial data was presented at the 19th European Colorectal Congress, indicating progress in treating moderate to severe ulcerative colitis [1] - Guizhou Bai Ling's actual controller is under investigation by the China Securities Regulatory Commission for insider trading and information disclosure violations [3] Group 2 - Bairen Medical's ePTFE pericardial membrane product has been approved for registration, ending the reliance on imports for this product in the domestic market [4] - Qianxin received approval for a total of 2 billion yuan in technology innovation bonds, with plans to issue medium-term notes and short-term financing bonds [6] - Tengjing Technology's shareholder plans to reduce holdings by no more than 1.96% of the company's shares [7] Group 3 - Yuntianhua's subsidiary is required to pay 386 million yuan in overdue taxes and penalties, which will impact the company's net profit for 2025 [8] - Jianyou Pharmaceutical's propofol emulsion injection has received FDA approval in the United States [9] - Suzhou Gaoxin successfully acquired land use rights for a residential project for 360 million yuan [9] Group 4 - Chalco International's subsidiary won a bid for a 3.03 billion yuan electrolytic aluminum project [11] - Tai Long Pharmaceutical's stock will continue to be suspended due to potential changes in control as the major shareholder is planning a share transfer [12] - Qianli Technology reported a 63.44% year-on-year increase in automobile sales for November, although new energy vehicle sales decreased by 43.98% [13] Group 5 - Fosun Pharma's innovative drug FXS0887 has received approval for a Phase I clinical trial for advanced malignant solid tumors [14] - Guoen Co. has obtained approval for a project to produce 20,000 square meters of aviation-grade acrylic glass, with a total investment of 560 million yuan [15] - Guofa Co.'s chairman resigned due to personal reasons [17] Group 6 - Shanghai Construction won a bid for a state-owned construction land use right for 264 million yuan [18] - Weixin Kang's subsidiary received approval for a clinical trial of lidocaine cream for local anesthesia [20] - Sanxing Medical's subsidiary is a candidate for a 152 million yuan transformer procurement project for the State Grid [20] Group 7 - People's Daily announced the resignation of its president due to work changes, while retaining other leadership roles [21] - Beibu Gulf Port reported a 0.29% year-on-year increase in cargo throughput for November [22] - Chongqing Construction won three engineering projects with a total value of approximately 2.773 billion yuan [23] Group 8 - Xingyu Co. is planning to issue H-shares and list on the Hong Kong Stock Exchange [24] - Huajian Group signed a design contract worth 160 million yuan for a comprehensive project [25] - Wankai New Materials plans to invest 350 million yuan in a technical transformation project for producing 100,000 tons of adipic acid [26] Group 9 - Kaipuyun received a government subsidy of 18 million yuan, which is 87.43% of its net profit for the last audited fiscal year [28] - Ningbo Port expects a 10.8% year-on-year increase in container throughput for November [30] - An Cai High-Tech plans to invest 498 million yuan to upgrade its photovoltaic glass production line [32] Group 10 - Shunhao Co. stated that its existing business has not generated synergies with the rail business, which faces various risks [34] - Yihualu plans to publicly transfer 35% of its stake in Liaoyun Company [35] - ST Wanfang's shareholder plans to reduce holdings by no more than 3% of the company's shares [36] Group 11 - Youyou Food's shareholder plans to reduce holdings by no more than 110,000 shares [38] - Hengtong Optic-Electric's incentive fund has spent 49.98 million yuan to purchase company shares [41] - Zoli Pharmaceutical plans to issue convertible bonds to raise no more than 1.556 billion yuan for various projects [42]

| | | 四川福蓉科技股份公司 股票交易风险提示公告 二、公司生产经营情况未发生重大变化 截至本公告日，公司主营业务、生产经营情况及经营环境与前期披露的信息 相比，未发生重大变化，公司不存在应披露而未披露的重大事项。敬请广大投资 者注意投资风险，理性投资。 1 三、媒体报道、市场传闻、热点概念情况 公司主要产品有消费电子产品铝制结构件材料、新能源和汽车铝型材及其精 深加工件。公司产品本身不具有 AI 功能，具体产品情况详见公司披露的定期报 告。公司生产的高强度铝制结构件材料已用于 MR、VR 眼镜，主要有三星、vivo 等品牌,但占公司营业收入比重极其有限。敬请广大投资者注意投资风险，理性 投资。 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 四川福蓉科技股份公司（以下简称"公司"）股票交易于 2025 年 12 月 1 日、 2025 年 12 月 2 日连续两个交易日内收盘价格涨幅偏离值累计超过 20%。根据《上 海证券交易所交易规则》的有关规定，属于股票交易异常波动。公司于 2025 年 12 月 3 日披露了 ...

Core Viewpoint - The stock of Furong Technology experienced significant price fluctuations, with a cumulative increase of over 20% from December 1 to 2, 2025, and a closing price of 13.30 yuan on December 3, 2025, indicating abnormal volatility [1] Group 1 - The static price-to-earnings ratio of the company is 75.52, which is considerably higher than the industry average of 58.28 [1] - The stock price saw a cumulative increase of 30.03% from December 1 to 3, 2025 [1] Group 2 - The company has indicated that there are no significant changes in its production and operations, and there are no undisclosed matters that need to be revealed [1] - The revenue contribution from materials used in MR and VR glasses is very low, and the company's products do not incorporate AI functionalities [1]

格隆汇12月3日｜福蓉科技（维权）公告，公司股票交易于2025年12月1日、2025年12月2日连续两个交 易日内收盘价格涨幅偏离值累计超过20%。根据《上海证券交易所交易规则》的有关规定，属于股票交 易异常波动。截至本公告日，公司主营业务、生产经营情况及经营环境与前期披露的信息相比，未发生 重大变化，公司不存在应披露而未披露的重大事项。公司主要产品有消费电子产品铝制结构件材料、新 能源和汽车铝型材及其精深加工件。公司产品本身不具有AI功能，具体产品情况详见公司披露的定期 报告。公司生产的高强度铝制结构件材料已用于MR、VR眼镜，主要有三星、vivo等品牌,但占公司营业 收入比重极其有限。 ...

格隆汇12月3日丨福蓉科技(603327.SH)公布，公司主要产品有消费电子产品铝制结构件材料、新能源和 汽车铝型材及其精深加工件。公司产品本身不具有AI功能，具体产品情况详见公司披露的定期报告。 公司生产的高强度铝制结构件材料已用于MR、VR眼镜，主要有三星、vivo等品牌,但占公司营业收入比 重极其有限。 ...

福蓉科技发布股票交易风险提示公告称，公司股票交易连续三个交易日以涨停价收盘。股票价格近期涨 幅较大，可能存在短期涨幅较大后的下跌风险。截至本公告日，公司主营业务、生产经营情况及经营环 境与前期披露的信息相比，未发生重大变化，公司不存在应披露而未披露的重大事项。公司主要产品有 消费电子产品铝制结构件材料、新能源和汽车铝型材及其精深加工件。公司产品本身不具有AI功能。 公司生产的高强度铝制结构件材料已用于MR、VR眼镜，主要有三星、vivo等品牌，但占公司营业收入 比重极其有限。 ...

| 交易日期 | 证券简称 | 证券代码 | 成交价(元) 成交金额(万元) 成交量( * ) 买入营业部 | | | | 卖出营业部 | | --- | --- | --- | --- | --- | --- | --- | --- | | | | | 61.4 | | 公司正臺在國星榮 | 国泰海通证券股份 有限公司福州杨桥 | | | 2025-12-03 | 福蓉科技 | 603327 | 11.12 | 682.77 | | | | 12月3日，福蓉科技大宗交易成交61.4万股，成交额682.77万元，占当日总成交额的0.31%，成交价11.12元，较市场收盘价13.3元折价16.39%。 ...